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Background: Acute gallstone disease is a high-volume emergency general surgery presentationwith wide
variations in the quality of care provided across the UK. This controlled cohort evaluation assessed
whether participation in a quality improvement collaborative approach reduced time to surgery for
patients with acute gallstone disease to fewer than 8days frompresentation, in linewith national guidance.
Methods: Patients admitted to hospital with acute biliary conditions in England and Wales between
1 April 2014 and 31 December 2017 were identified from Hospital Episode Statistics data. Time
series of quarterly activity were produced for the Cholecystectomy Quality Improvement Collaborative
(Chole-QuIC) and all other acute National Health Service hospitals (control group). A negative binomial
regression model was used to compare the proportion of patients having surgery within 8 days in the
baseline and intervention periods.
Results: Of 13 sites invited to join Chole-QuIC, 12 participated throughout the collaborative, which ran
from October 2016 to January 2018. Of 7944 admissions, 1160 patients had a cholecystectomy within
8 days of admission, a significant improvement (P<0⋅050) from baseline performance. This represented
a relative change of 1⋅56 (95 per cent c.i. 1⋅38 to 1⋅75), compared with 1⋅08 for the control group. At the
individual site level, eight of the 12 Chole-QuIC sites showed a significant improvement (P< 0⋅050), with
four sites increasing their 8-day surgery rate to over 20 per cent of all emergency admissions, well above
the mean of 15⋅3 per cent for control hospitals.
Conclusion: A surgeon-led quality improvement collaborative approach improved care for patients
requiring emergency cholecystectomy.
∗Other members of the Cholecystectomy Quality Improvement Collaborative are listed under the heading Collabora-
tors.
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Introduction
Gallstone-related disease accounts for approximately
one-third of emergency general surgery admissions and
referrals1. The commonest presentation is acute biliary
pain (56 per cent), followed by acute cholecystitis (36 per
cent) and gallstone pancreatitis (4 per cent). The majority
of patients presenting to hospital with biliary pain go
on to have a cholecystectomy as definitive treatment.
Around 20–33 per cent of patients with acute cholecys-
titis or pancreatitis will re-present with gallstone-related
symptoms before they have a cholecystectomy2–4. Current
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national guidance from the UK National Institute for
Health and Care Excellence (NICE) is for laparo-
scopic cholecystectomy to be done within 7 days of a
diagnosis of acute cholecystitis, and within the index
admission for pancreatitis5. Guidelines from the Inter-
national Hepato-Pancreato Biliary Association, World
Society of Emergency Surgery and British Society of
Gastroenterologists provide similar guidance on times to
cholecystectomy6–8.
Reducing the time to surgery for people who need a
cholecystectomy minimizes the number of times patients
are readmitted with the same diagnosis and decreases the
overall length of hospital stay. Compared with delayed
cholecystectomy, emergency procedures are associated
with overall fewer work-days lost, greater patient sat-
isfaction and better quality of life3. Patients with acute
pancreatitis run the risk of a fatal episode whilst await-
ing cholecystectomy that can be reduced by early biliary
surgery. Concerns of complications resulting from conver-
sion from laparoscopic to open surgery or increased risks
of bile duct injury with emergency compared with delayed
surgery are not supported by current evidence9–19. Several
studies have tried to identify the optimal time within the
first week of admission, and some14,15, though not all20,
have shown a lower conversion rate if surgery is possi-
ble within 72 h. Meta-analysis of available studies has not
shown a higher incidence of bile duct injury, which remains
similar to that in patients having delayed surgery21–23.
Across studies20–24, patients who have surgery after 72 h
still do better on all indicators than those in delayed groups.
Patients in the UK with symptomatic gallstones wait
longer and are more likely to be readmitted than those
in many other countries. Patients in France, the USA and
Australia tend to undergo cholecystectomy on first admis-
sion with an average length of stay under 36 h15,25,26. The
majority of patients diagnosed with acute cholecystitis in
the USA have an emergency cholecystectomy on the same
admission, compared with only 16 per cent in England1.
Within the UK there is wide variation between National
Health Service (NHS) hospitals in the management of
these patients27, and wide variation in cholecystectomy
rates despite NICE guidance5.
The goal of the Cholecystectomy Quality Improvement
Collaborative (Chole-QuIC) was to see whether a collab-
orative quality improvement (QI) programme could be
used to improve emergency cholecystectomy rates. The
evaluation was designed to identify whether improvements
could be achieved by hospitals as a result of participa-
tion in Chole-QuIC, what influenced change, and what
lessons might be drawn for future improvement efforts.
This article presents the quantitative outcome evaluation
findings, using routinely collected administrative hospital
data to answer the question: ‘Did participation in a quality
improvement collaborative (Chole-QuIC) reduce time to
surgery to within 8 days from admission for patients requir-
ing emergency cholecystectomy?’. The findings from the
process evaluation have been published separately28.
Methods
The Chole-QuIC study ran from October 2016 to January
2018 as a modified version of the Institute of Health-
care Improvement Breakthrough Series collaborative
approach, incorporating evidence related to this QI
approach (Table 1)29–32. Recruitment to the collaborative
was through open application, followed by a selection
process. Some 13 of the 29 hospitals that applied were
selected to participate. Criteria for selection involved: the
ability of the site to commit sufficient surgical and support
time to the programme; and sufficient room for improve-
ment and no ongoing related improvement projects. The
selected hospitals covered a range of hospital size and sur-
gical volume, with three sites that also provided specialist
hepatobiliary services.
The aim of the collaborative was to demonstrate that
time to emergency cholecystectomy could be reduced
for eligible patients with acute biliary pain, cholecystitis
or gallstone pancreatitis, by using QI methodologies to
enable clinicians to drive change within their own insti-
tutions. Surgery within 8 days of presentation was chosen
to match current NICE guidelines for acute cholecystitis
(surgery within 7 days of diagnosis), plus one additional
Table 1 The Chole-QuIC process for developing and delivering
an evidence-based quality improvement collaborative
The right problem
Choosing a problem with common agreement that needs fixing in this
context (defined by stakeholders) and motivation from participants to
solve
Clearly defining and articulating the problem
Measuring and monitoring
Data collection, to understand the local demand, the size of the
challenge and patient flow through the actual pathway
Data analysis and feedback to monitor progress and motivate
colleagues
Support and collaboration
Sharing of ideas and outcomes with the collaborative; learning from
other attempts and adapting local processes accordingly
Expert clinical and quality improvement support, training and coaching
The right solutions
Generating context-specific solutions or new processes (supported by
best evidence of any previous solutions)
Testing these solutions, and adapting to what works well or does not
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day from presentation to allow time for diagnosis5. Eligible
patients were those who agreed to have their operation
(cholecystectomy) on an emergency basis and were deemed
to be clinically fit for surgery, as assessed by local clinical
teams. This patient population was chosen as it covered the
majority of patients with symptomatic gallstones following
a similar clinical pathway1.
Fig. 1 shows the clinical pathway for patients requiring
emergency cholecystectomy. There was no evidence to
suggest that a single, universally applicable, organizational
approach would achieve this goal; rather, successful change
would require concerted short-term resources to imple-
ment behavioural, process and system improvements.
Consequently, the collaborative was designed to support
site teams to develop, test and ultimately implement
context-specific solutions that would move their service
toward achieving the project goal. Teams were supported
throughout the collaborative process in a number of ways
(Table 1). A series of four collaborative meetings, designed
to help teams learn about improvement methods and share
progress and ideas with one another, was organized; webi-
nars between meetings were used to maintain momentum
and to keep each centre updated; and site visits were
undertaken by the Chole-QuIC team to support teams
to make improvements and overcome specific challenges.
The Chole-QuIC team also provided assistance with
analysis of locally collected audit data, to help
teams track their own progress. Full details of
the Chole-QuIC intervention have been published
elsewhere28.
Study design
A mixed-methods evaluation was approved by the ethics
review board of Queen Mary University of London
(QMREC1817a). NHS Research Ethics Committee
approval was not required for the analysis of anonymized
routine data for service evaluation. Project findings
are reported in accordance with Standards for QUal-
ity Improvement Reporting Excellence (SQUIRE)
guidelines33 for the publication of QI work.
Informed consent was obtained from all participants and
written information was provided at the start of the pro-
gramme about the purpose of the evaluation, the voluntary
nature of participation, and assurances that no individual
or hospital-level data would be disclosed.
Fig. 1 Chole-QuIC pathway for patients with acute biliary pain, cholecystitis or gallstone pancreatitis
Patients with severe symptomatic gallstone disease
Refer to GP
Time of
presentation
Time of
admission
In medical
ward
Time of
surgery
Present at
emergency department
Present at surgical assessment unit or equivalent
Clinical assessment
(including amylase, liver function and inflammatory markers)
Emergency admission
Surgical consultant review and gallstones confirmed
(via new or previous ultrasound image)
Elective
cholecystectomy
pathway
No surgery
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Lighter coloured boxes on the right relate to patients who drop out of the Chole-QuIC pathway because further diagnostic information is received or the
patient chooses not to have an emergency cholecystectomy. GP, general practitioner.
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Fig. 2 Admissions and 8-day rates for baseline and intervention periods in Chole-QuIC cohort and control group
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Data collection
This evaluation used routine hospital data on all patients
admitted as an emergency with acute biliary pain,
cholecystitis or gallstone pancreatitis (ICD-10 codes
K85.0, K85.1, K85.8, K85.9; K80.0, K80.1, K80.2; K81.0,
K81.1, K81.8, K81.9; K82.0, K82.1, K82.2, K82.3, K82.4,
K82.8, K82.9; R10) who subsequently had a cholecystec-
tomy, from 1 April 2014 to 31December 2017. For English
NHS trusts, aggregate quarterly figures were derived from
the English Hospital Episode Statistics database; for
Welsh Health Boards, data were obtained from the Patient
Episode Database for Wales. Key variables were the num-
ber of patients admitted as an emergency with an eligible
condition and the number of patients who had emergency
or elective surgery (OPCS J18) within 8 days of emergency
admission. Some quarterly values were masked as ‘< 5’;
for analysis, values between 1 and 4 for the masked values
were imputed by multiplying the emergency admissions
with the typical ratio for that NHS trust (up to a maximum
of 4 patients).
QI data were collected by hospital teams for all patients
on the Chole-QuIC clinical pathway (Fig. 1), including
patient eligibility, time to surgery, and whether the patient
had an inpatient cholecystectomy, was discharged for an
urgent cholecystectomy, or was temporarily or perma-
nently unfit for surgery. Anonymized summary data were
shared with the Royal College of Surgeons core team, using
an encrypted e-mail service. Run charts and statistical pro-
cess control charts were created from these summary data
to assess local improvements, including changes to mean
and median times to surgery, and 3- and 14-day surgery
© 2019 The Authors. www.bjsopen.com BJS Open
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
Evaluation of a quality improvement collaborative approach for emergency cholecystectomy
Table 2 Chole-QuIC and control 8-day surgery rates and individual site data
Activity (all admissions
for biliary disease)
% of procedures
within 8days
(all admissions)
Baseline Intervention Baseline Intervention
Relative change
from baseline
Relative change
for combined
model (adjusted for
control group)
All Chole-QuIC 13929 7944 9⋅4 14⋅6 1⋅56 (1⋅38, 1⋅75)* 1⋅45 (1⋅29, 1⋅62)*
Control 147495 83391 14⋅2 15⋅3 1⋅08 (1⋅02, 1⋅14)*
Site no.
1 521 301 8⋅8 25⋅9 2⋅94 (2⋅02, 4⋅27)* 2⋅73 (1⋅88, 3⋅96)*
2 964 521 12⋅2 26⋅5 2⋅16 (1⋅69, 2⋅77)* 2⋅01 (1⋅55, 2⋅60)
3 513 355 16⋅8 35⋅2 2⋅10 (1⋅60, 2⋅76)* 1⋅95 (1⋅47, 2⋅59)
4 1103 629 9⋅9 20⋅8 2⋅09 (1⋅45, 3⋅01)* 1⋅96 (1⋅50, 2⋅55)*
5 1333 770 4⋅6 8⋅6 1⋅88 (1⋅27, 2⋅77)* 1⋅74 (1⋅22, 2⋅49)*
6 1114 619 8⋅5 14⋅7 1⋅72 (1⋅06, 2⋅79)* 1⋅60 (1⋅19, 2⋅16)*
7 1189 627 6⋅7 11⋅2 1⋅68 (1⋅06, 2⋅65)* 1⋅54 (1⋅11, 2⋅15)*
8 1413 900 14⋅4 19⋅6 1⋅35 (1⋅11, 1⋅66)* 1⋅26 (1⋅01, 1⋅56)*
9 1213 684 6⋅5 8⋅3 1⋅28 (0⋅88, 1⋅85) 1⋅19 (0⋅84, 1⋅68)
10 1476 760 8⋅4 8⋅8 1⋅03 (0⋅64, 1⋅66) 0⋅97 (0⋅72, 1⋅33)
11 1505 793 2⋅9 3⋅0 1⋅02 (0⋅59, 1⋅77) 0⋅96 (0⋅58, 1⋅59)
12 1585 985 16⋅5 14⋅2 0⋅86 (0⋅69, 1⋅09) 0⋅80 (0⋅64, 100)
Values in parentheses are 95 per cent confidence intervals. *P< 0⋅050 (negative binomial regression).
Fig. 3 Percentage of procedures within 8 days of admission in baseline and intervention periods
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Fig. 4 Statistical process control chart for all patients who had surgery in the 12 participating sites
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rates. These data were fed back to teams monthly, starting
3months before the start of the study, to support improve-
ment, and were analysed as part of the evaluation.
Data analysis
Time series of quarterly activity were produced for: each
of the English andWelsh NHS organizations participating
in Chole-QuIC; the English and Welsh site Chole-QuIC
cohort as a whole; and a combined English and Welsh
control group, consisting of 127 English acute NHS trusts
and five Welsh Health Boards.
The time series was divided into three segments: nine
quarters from April 2014 to June 2016 represented the
baseline period (baseline); one quarter from July to
September 2016 was considered a transition period; and
five quarters from October 2016 to December 2017 repre-
sented the intervention period (intervention). A negative
binomial regression model was used to assess whether the
proportion of patients having surgery within 8 days had
changed in the intervention compared with the baseline
period. The model only assessed whether there had been
a change in the mean level of the time series, because it
was too short to test for (changes in) trends. A second
model, with the relative difference adjusted for the change
Table 3 Description of key influences
Achieving clarity of purpose amongst site leads and all key
stakeholders
Creating additional capacity to do urgent cholecystectomies.
Solutions include:
Ring-fencing half-day elective lists for hot gallbladders
Persuading additional surgeons to carry out operations on hot
gallbladders
Holding a slot on emergency theatre lists (CEPOD) for hot gallbladders
Coordinating/managing the patient pathway effectively. Solutions
include:
E-mail referral system
Real-time review systems, such as whiteboard in surgical assessment
unit listing details of all eligible admissions
Virtual wards
Other cognitive, relational and behavioural work
Capacity (time and resources) to lead and effective team working
Ideas to action – e.g. testing ideas quickly
Learning from own and others’ experience – e.g. changing approaches
upon review, adding new innovations over time
CEPOD, Confidential Enquiry into Perioperative Deaths.
observed in the control group, was also used. A negative
binomial regression model was preferred to a Poisson
model as it allowed for overdispersion.
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A statistical process control (SPC) chart was created from
the time to surgery for all eligible patient admissions that
had a cholecystectomy at any of the 12 participating sites,
using locally collected data. The analysis was undertaken
using Stata® version 15.1 (StataCorp, College Station,
Texas, USA). Time to surgery was plotted by date of
presentation, and upper and lower control limits were
calculated at three standard deviations from the mean time
to surgery. Following standard practice for SPC chart
interpretation, mean and control limits were recalculated
when a shift (9 or more successive data points above or
below the mean) was identified. A shift is a data signal
in an SPC chart that indicates a special cause variation,
analogous to a significant, non-random, change in the data
(P< 0⋅050)34,35.
Results
Of the 13 sites invited to join Chole-QuIC, 12 participated
fully throughout the programme, with teams attending all
four collaborative meetings, three webinars, participating
in at least one site visit, collecting prospective data and
testing improvement ideas. Site 13 withdrew voluntarily
after 9months, having engaged to only a limited extent (no
attempt at service changes, incomplete local data collec-
tion), and was included only in the control group in the
main analyses.
In total there were just under 8000 acute biliary admis-
sions across the Chole-QuIC cohort of 12 during the
15-month intervention period: 5390 with acute biliary
pain or cholecystitis, and 2554 with acute pancreatitis.
Some 1160 patients had a cholecystectomy within 8 days
of admission, 428 more than in the previous 15months.
A significant increase in the 8-day surgery rate was iden-
tified, above any national trend toward improvement, for
sites participating in Chole-QuIC, with an increase in the
quarterly mean of emergency cholecystectomies for all 12
sites, from 145⋅5 in the baseline period to 232⋅0 in the inter-
vention period. Although the number of emergency admis-
sions stayed relatively stable for both the Chole-QuIC and
the control group (the other 127 hospitals across Eng-
land and 5 Health Boards Wales), the percentage of pro-
cedures within 8 days rose, with the control group 8-day
rate increasing slightly (from 14⋅2 to 15⋅3 per cent) and the
Chole-QuIC group increasing markedly, from a mean of
9⋅4 per cent during the baseline period to 14⋅6 per cent in
the intervention period (Fig. 2). This improvement repre-
sented a relative change of 1⋅56, compared with 1⋅08 for the
control group; accounting for the national trend towards
improvement in the control group gives a relative change
of 1⋅45 (95 per cent c.i. 1⋅29 to 1⋅62) (Table 2).
At the individual site level, eight of the 12 sites had a
significant improvement (P< 0⋅050) in the 8-day surgery
rate above the national trend towards improvement; in four
sites, the 8-day surgery rate increased to over 20 per cent
of all emergency admissions (Table 2). As a comparator,
between 2014 and 2018, 8-day surgery rates were between
2 and 48 per cent across England and Wales, with the top
quartile across England and Wales achieving a median of
26 (range 21–48) per cent. Fig. 3 illustrates the ranking
of Chole-QuIC sites for the 8-day surgery rate compared
with all English and Welsh trusts over the baseline and
intervention periods. All but two (sites 11 and 12) of the
Chole-QuIC sites improved their ranking in emergency
surgery rates among English and Welsh hospitals (Fig. 3),
with three moving into the top quartile and two of three
moving from the fourth to third quartiles. Sites 11 and 12
saw concurrent reductions in performance.
Fig. 4 presents the locally collected data on time to
surgery for the 1580 patients who had a cholecystectomy
following emergency admission, from a total of 3001, dur-
ing the improvement period. Although the percentage
of eligible patients undergoing cholecystectomy remained
consistent throughout the project (ranging from 44 to 69
per cent), the mean time to surgery for these patients
improved over time, and variation reduced. Mean time to
surgery decreased from 22⋅6 days at the project start to a
low of 12⋅0 days (September to October 2017), finishing at
16⋅5 days in December 2017. Variation in time to surgery
also reduced substantially over time: from September 2017,
breaches to the upper control limit became rare, despite a
concurrent tightening of the control limits.
Discussion
The main finding of this evaluation was that eight of
12 hospitals participating in a QI collaborative were able
to increase early cholecystectomy rates significantly for
patients with gallstone disease requiring hospital admis-
sion, in line with national guidance. As this was a con-
trolled cohort evaluation, it was possible to account for any
trend towards improvement in the remaining 127 hospitals
in England and Wales. Results remained significant when
the small national improvement trend was accounted for.
When plotted on SPC charts, locally collected data showed
a clear reduction in variability and increase in reliability in
providing timely laparoscopic cholecystectomy across the
Chole-QuIC cohort.
Regarding the 8-day surgery rate, the cohort mean of
14⋅6 per cent remained below the national control group
average of 15⋅3 per cent. This is explained partly by the
large range of outcomes between the 12 (3⋅0–35⋅2 per cent)
© 2019 The Authors. www.bjsopen.com BJS Open
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
J. R. Bamber, T. J. Stephens, D. A. Cromwell, E. Duncan, G. P. Martin, N. F. Quiney et al.
and partly by the selection criteria for inclusion in the pro-
gramme. Sites were chosen with room for improvement
that were not currently involved in improvement activ-
ities in this area. It is important to stress that this was
an improvement programme where changes were intro-
duced throughout the 15months, not introduced in totality
at the start. When interpreting these rates, only five of
the 127 English trusts and no Welsh hospitals achieved
an 8-day surgery rate above 35 per cent between 2014
and 2017 (Fig. 3). These data may appear low as the
denominator includes all patients recorded with relevant
ICD-10 codes. Clinical assessments by the participating
site teams suggested that a large proportion of patients
in this denominator group were not eligible for surgery.
For patients who were suitable for early surgery, this
study showed that it was possible for hospitals to improve
their service significantly to ensure these patients received
timely surgery.
The variation in outcomes between the 12 sites sug-
gests that there are particular factors that aid or hin-
der successful improvement. Several important themes
emerged from the concurrentmixed-methods process eval-
uation, which looked at the characteristics of the four most
successful sites compared with the four least successful
sites (Table 3)28.
Intensive work was required to ensure that all stake-
holders within teams had a shared understanding of, and
agreement with, the purpose and benefits of rapid surgical
intervention for this patient group. Divergent views on the
value of this approach amongst key stakeholders (surgeons,
senior service managers and staff gatekeeping emergency
theatre lists) seemed to be the most significant barrier to
improvement. At many sites, these patients were seen as
comparable to patients presenting with acute appendicitis,
and the Chole-QuIC sites that improved most focused on
changing the local culture and approach in relation to this
patient group.
Sites exhibiting the greatest improvement used a mul-
tifaceted approach to creating additional theatre capacity,
for example improving use of emergency lists while also
ring-fencing slots within elective lists to provide urgent
surgery for these emergency admissions. An effective coor-
dination process for patients moving along the commonly
agreed pathway was important to optimize the use of any
additional capacity created and to allay concerns about
potential waste from ring-fencing.
Cognitive, relational and behavioural issues, such as hav-
ing dedicated time for site leads to run the improvement
project locally and turning ideas into action early on in
the project, were found to define the most successful sites.
These four interlinked factors needed to be developed over
time. Achieving clarity of purpose appeared a necessary
precondition. The more challenged sites failed to achieve
sufficient stakeholder support from all parties, which ham-
pered their ability to implement improvements to capacity
and coordination processes28.
National gallstone registries in both Sweden and Den-
mark have been credited with facilitating overall improve-
ments in quality of care through benchmarking36,37, but
more active efforts to use QI methods have not been
undertaken. Surgeon-led improvement collaboratives
appear rare, with a recent systematic review38 of published
improvement collaborative evaluations finding that only
a small number focused on improving care for surgical
patients, and only one in general surgery. With regard to
the success of this collaborative, the robustness of the eval-
uation design and the results achieved compare favourably
with the outcomes of previous QI collaboratives in other
areas of healthcare. Although this is likely to be due, in
part, to an effective evidence-based intervention design,
the motivation and efforts of the site teams are likely to be
a major contributor to the relative success of Chole-QuIC.
This reinforces the argument that QI collaboratives should
focus on an issue or problem for which there is a strong
consensus that change is required, especially when both
problem and solution identification are supported by a
respected professional body28,32.
This evaluation has several strengths, including the use
of registry data that facilitated both a substantial base-
line data period and comparison with a control group to
observe both cohort and national trends toward improve-
ments in care for this patient group. The evaluation also
has limitations. Sites volunteered to participate and thus a
commitment to provide surgical and support time for the
duration of the project was present in the sites that may
not be generalizable. To demonstrate that improvements
could be achieved and sustained in a range of contexts,
the programme was designed to select sites with capac-
ity for improvement. Most sites therefore had baseline
performance with regard to the 8-day rate below the
national average. As five of the eight members of the
evaluation team were directly involved in delivering this
programme, there is a risk of bias in the analysis, which
was mitigated by ensuring that an independent researcher
carried out the quantitative analysis and an independent
evaluation expert regularly reviewed processes to provide
both internal and face validity. Some potentially relevant
outcome data were not available for analysis from routine
national data, including readmission rates, 14-day rates,
or median and mean time to surgery. Balancing measures
such as positive or negative impact on waiting times for
other patient groups were not looked at, and neither was
© 2019 The Authors. www.bjsopen.com BJS Open
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the sustainability of these outcomes, as national data were
available only to December 2017.
A surgeon-led QI collaborative approach can be effective
at improving care for patients requiring emergency chole-
cystectomy. The learning from this collaborative should be
useful for others wishing to improve care for patients with
acute gallstone-related disease and potentially for other
surgical patient groups where current care is below the
standards set by national guidance.
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